For high-risk populations such as individuals with a family history or genetic mutations, gene mutations significantly related to the pathogenesis of pancreatic cancer can be detected, such as KRAS, TP53, SMAD4, BRCA1, BRCA2, CDKN2A, and PALB2 [5,6,7]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.